Managing Toxicity Seen With Linvoseltamab in R/R Multiple Myeloma
Hans C. Lee, MD, discusses the toxicity seen with the BCMA/CD3 bispecific antibody linvoseltamab for patients with relapsed/refractory multiple myeloma.